Yartemlea Injection
Product Images NDC 62225-300

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Yartemlea (NDC 62225-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Omeros Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (370mg Carton Label)

Packaging label for YARTEMLEA (narsoplimab-wuug) injection, 370 mg/2 mL (185 mg/mL) for intravenous infusion after dilution. The label shows it is a 2 mL single-dose vial with instructions to discard unused portion. Manufactured by Omeros Corporation, Seattle, WA, with patent information and storage instructions to keep refrigerated at 2°C to 8°C.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.